The aim of this article is to create awareness among medical colleagues regarding the severe ophthalmic side effects associated with topiramate use.
Methods:
A case of severe acute bilateral angle closure glaucoma with visual blurring after oral topiramate therapy.
Results:
This case was successfully managed by discontinuing topiramate and by starting anti-glaucoma medication. Intraocular pressure, acute transient myopia, and anterior chamber depth were normalized.
Conclusions:
It is important for clinicians to recognize these conditions and educate patients about these serious adverse effects when prescribing topiramate.
SenthilS., GarudadriC., RaoH.B.L., MaheshwariR.Bilateral simultaneous acute angle closure caused by sulphonamide derivatives: a case series. Indian J. Ophthalmol., 58:248–252. 2010.
6.
ChalamK.V., TillisT., SyedF., AgarwalS., BrarV.S.Acute bilateral simultaneous angle closure glaucoma after topiramate administration: a case report. J. Med. Case Rep., 2:1. 2008.
7.
CraigJ.E., OngT.J., LouisD.L., WellsJ.M.Mechanism of topiramate-induced acuteonset myopia and angle closure glaucoma. Am. J. Ophthalmol., 137:193–195. 2004.
